Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp

Bullboard Posts

Post by cardshark1on Aug 28, 2003 11:37pm

245 Views

Post# 6363863

From..

Cannacord. Lexxor Energy (LXX : TSX : $1.70), Net Change: 0.00, % Change: 0.00%, Volume: 48,700 Every move you make, every claim you stake, I'll be watching you. Lexxor is one junior oil and gas stock you will want to watch. High flying Blue Mountain Energy (GAS) will have to look for a new VP of Exploration after Nick Wymyss bolted to join Find Energy. Find is to form from the merger of Lexxor Energy and Sine Energy, assuming that shareholders vote in favour on September 10. At Find Energy, Wymyss will be reunited with Bill Davis, Doug Barry and Jeff Jongmans who made up the management team at Search Energy before it was converted to a royalty trust.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity